Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Serum interleukin-6 concentration in patients with pemphigus

Thai Van Thanh Le, Anh Tuan Ngo, Quoc Hung Ta, The Bich Thanh Vuong

01-02-2024

https://doi.org/10.4081/dr.2024.9868

891

PDF: 468

HTML: 25
Autoinflammatory diseases: what is behind them and what is new?

Michele Maalouly, Serena Saade, Mazen Kurban

29-12-2022

https://doi.org/10.4081/dr.2023.9625

1856

PDF: 588

HTML: 158
Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum

Fitri Kadarsih Banjar, Farida Tabri, Sri Vitayani Muchtar, Mochammad Hatta, Khaeruddin Djawad, Farida Ilyas, Sitti Musafirah, Muhammad Nasrum Massi, Agussalim Bukhari, Andi Alfian Zainuddin

12-09-2023

https://doi.org/10.4081/dr.2023.9773

964

PDF: 485

HTML: 24
Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Chuyen Thi Hong Nguyen, Liem Viet Quoc Tran

27-11-2024

https://doi.org/10.4081/dr.2024.10090

845

PDF: 416

HTML: 32
Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata

Trang Thi Thuy Le, Thang Tat Nguyen, Chuyen Thi Hong Nguyen, Hao Trong Nguyen, Trung The Van

27-10-2021

https://doi.org/10.4081/dr.2021.9398

3155

PDF: 605

HTML: 15
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

1144

PDF: 570

HTML: 25
Neutrophilic urticarial dermatosis without systemic disease: case report

Sukaina Al Haddad, Abdulrahman Alfawzan, Maisa Alfalah , Manea Alharbi

30-01-2024

https://doi.org/10.4081/dr.2024.9756

994

PDF: 748

HTML: 49
Atopic dermatitis: a brief review of recent advances in its management

Sultan Daghafak Alenazi

23-05-2023

https://doi.org/10.4081/dr.2023.9678

2489

PDF: 1443

HTML: 122
Implications of interleukin-17 in psoriatic lesions as Koebner phenomenon caused by recurrent occupational burns

Ayumi Sato, Takeshi Fukumoto, Ai Yoshioka, Chikako Nishigori

27-10-2022

https://doi.org/10.4081/dr.2022.9567

1019

PDF: 537

HTML: 19
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

1318

PDF: 636

HTML: 26
Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo

Louise Rottboell, Sarah de Foenss, Kenneth Thomsen, Helle Christiansen, Stine M. Andersen, Thomas N. Dam, Cecilia Rosada, Karin Stenderup

17-12-2015

https://doi.org/10.4081/dr.2015.6246

3213

PDF: 971

HTML: 763
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

12-11-2024

https://doi.org/10.4081/dr.2024.10080

1320

PDF: 727

HTML: 38
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

13-09-2023

https://doi.org/10.4081/dr.2023.9839

2831

PDF: 1005

HTML: 35
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo

30-05-2025

https://doi.org/10.4081/dr.2025.10414

820

PDF: 452

HTML: 34
Immunohistochemical expression of interleukin β in papule biopsies from patients with acne vulgaris

Le Thai Van Thanh, Le Vi Anh, Tran Huong Giang, Ta Quoc Hung, Van The Trung, Nguyen Lam Vuong

17-03-2022

https://doi.org/10.4081/dr.2022.9444

1219

PDF: 622

HTML: 30
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

21-11-2022

https://doi.org/10.4081/dr.2022.9447

1414

PDF: 425

HTML: 47
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

22-05-2023

https://doi.org/10.4081/dr.2023.9630

1105

PDF: 587

HTML: 89
Telangiectasia Macularis Eruptiva Perstans: more than skin deep

Casey E. Watkins, Winston B. Bokor, Stuart Leicht, George Youngberg, Guha Krishnaswamy

e12

29-07-2011

https://doi.org/10.4081/dr.2011.e12

11771

PDF: 2241

HTML: 2306
Mendelian randomization analysis of the causal relationship between immune cells and keloid

Jingwen Zou, Pengkhun Nov, Kunpeng Du

23-10-2024

https://doi.org/10.4081/dr.2024.10106

819

PDF: 443

SUPPLEMENTARY MATERIAL: 158

HTML: 19
Refractory pityriasis rubra pilaris treated with abrocitinib

Filip Rob

09-01-2025

https://doi.org/10.4081/dr.2025.10105

479

PDF: 315

HTML: 22
Successful use of dupilumab in a patient with atopic dermatitis and autosomal dominant polycystic kidney disease: a case report

Arlind Kalaja, Barbara Cocuroccia, Donatella Sordi, Anna Dattolo, Sabatino Pallotta, Ignazio Stanganelli, Filomena Russo

04-06-2026

https://doi.org/10.4081/dr.2026.10522

337

PDF: 174
Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series

Andrea D'Arino, Maria Concetta Fargnoli, Pasquale Frascione, Chiara Assorgi, Annunziata Dattola, Viviana Lora, Matteo Megna, Flavia Pigliacelli, Emanuele Vagnozzi, Diego Orsini

30-07-2025

https://doi.org/10.4081/dr.2025.10379

532

PDF: 365

HTML: 7
Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

11-11-2024

https://doi.org/10.4081/dr.2024.10140

1055

PDF: 566

SUPPLEMENTARY MATERIAL: 180

HTML: 20
Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

11-10-2017

https://doi.org/10.4081/dr.2017.7079

1420

PDF: 679

HTML: 146
Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors

Anna Paola Lugli, Niccolò Gori, Elena Ippoliti, Benedetta Ambrosio, Ketty Peris

03-02-2026

https://doi.org/10.4081/dr.2026.10644

703

PDF: 440

1 - 25 of 103 items 1 2 3 4 5 > >>

Search

Search Results

Serum interleukin-6 concentration in patients with pemphigus

Autoinflammatory diseases: what is behind them and what is new?

Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum

Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Neutrophilic urticarial dermatosis without systemic disease: case report

Atopic dermatitis: a brief review of recent advances in its management

Implications of interleukin-17 in psoriatic lesions as Koebner phenomenon caused by recurrent occupational burns

Erythrodermic psoriasis improved by tildrakizumab

Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo

Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

Immunohistochemical expression of interleukin β in papule biopsies from patients with acne vulgaris

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Telangiectasia Macularis Eruptiva Perstans: more than skin deep

Mendelian randomization analysis of the causal relationship between immune cells and keloid

Refractory pityriasis rubra pilaris treated with abrocitinib

Successful use of dupilumab in a patient with atopic dermatitis and autosomal dominant polycystic kidney disease: a case report

Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series

Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors

authors

reviewers

Categories

indexing

dermatopathology